|Articles|November 1, 2001
- Applied Clinical Trials-11-01-2001
- Volume 8
- Issue 11
Stephen Senn
Moving between the UK and Switzerland, and between academia and industry has given Editorial Advisory Board member and statistician Stephen Senn a well-rounded view of pharmaceutical development.
Advertisement
Articles in this issue
almost 25 years ago
Enterprise Services Automation Softwarealmost 25 years ago
Bridging the Gap Between IT and Clinical Operationsalmost 25 years ago
Wireless Data: Challenges in the New New Economyalmost 25 years ago
Educating Investigators to Understand When to Break the Blindalmost 25 years ago
Bioterrorism and Research Policyalmost 25 years ago
Thinking Ahead on Clinical ResearchAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
3
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
4
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
5